Close Menu
Pet Business World
  • Trade News
    • Distributors
    • International
    • Legislation
    • Manufacturers
    • Other trades
    • Retailers
  • New Products
    • Birds
    • Cats
    • Dogs
    • Small Animals
  • Features
    • Industry Experts
    • Retailer profiles
  • Aquatics
  • Columnists
    • Newshound
    • Reptile Trade Views
  • People
  • Magazines
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
  • Classifieds
  • Trade Directory
  • Advertise
  • Email Newsletters
  • Subscribe
Facebook X (Twitter)
  • FREE Email Newsletters
  • About Us
  • Advertise
  • Contact Us
  • Free Magazine Subscriptions
X (Twitter) Facebook
Pet Business World
  • Trade News
    • Distributors
    • International
    • Legislation
    • Manufacturers
    • Other trades
    • Retailers
  • New Products
    • Birds
    • Cats
    • Dogs
    • Small Animals
  • Features
    • Industry Experts
    • Retailer profiles
  • Aquatics
  • Columnists
    • Newshound
    • Reptile Trade Views
  • People
  • Magazines
    1. June 2026
    2. May 2026
    3. April 2026
    4. March 2026
    5. February 2026
    6. January 2026
    7. December 2025
    8. November 2025
    9. October 2025
    Featured

    PBW News – June 2026

    By David ReesJune 10, 2026
    Recent

    PBW News – June 2026

    June 10, 2026

    PBW News – May 2026

    May 14, 2026

    PBW News – April 2026

    April 10, 2026
  • Classifieds
  • Trade Directory
Pet Business World
Legislation

Last day of evidence for pet parasite medication inquiry

David ReesBy David ReesJune 23, 20261 Min Read
Facebook Twitter LinkedIn Email
Share
Facebook Twitter LinkedIn Email

The House of Lords Environment and Climate Change Committee is hearing the final day of in-person evidence on pet parasite medication today (June 23).

The short inquiry focused on treatments containing pesticides of concern such as fipronil and imidacloprid and was triggered by concerns raised by the Veterinary Medicines Directorate (VMD) and the Environment Agency about the presence of these chemicals in British watercourses, potentially damaging the delicate ecosystems. The VMD has proposed changing the status of certain pet parasite treatments from a general licence to restricting them for sale only through vets, pharmacists, or Suitably Qualified Persons (SQPs) in stores.

Giving evidence today are Baroness Hayman of Ullock, Parliamentary Under-Secretary of State at government department Defra; Abigail Seager and Francine Fernandez from the VMA; and Dr Robert Bradburne, chief scientist at the Environment Agency.

The committee is expected to ask about the evidence base for suggested environmental impacts of the chemicals, and the current sufficiency of advice and guidance to pet owners regarding treatments.

Previous ArticleNew bone broth toppers from Encore
Next Article Omni Pet raises £11m to boost new products and retail entry
David Rees

David Rees is the editor of PBW News. In a 30-year career in trade journalism he has specialised in the retail and wholesale sectors, holding senior positions at a number of leading titles.

Read Similar Stories

Legislation

NOAH gives evidence to pet parasite medication inquiry

June 17, 2026
Legislation

PIF creates supplement marketing tool

June 17, 2026
Legislation

Parasite medicine inquiry continues

June 10, 2026
Most Read

Omni Pet raises £11m to boost new products and retail entry

June 23, 2026

Last day of evidence for pet parasite medication inquiry

June 23, 2026

New bone broth toppers from Encore

June 23, 2026
© 2026 Lewis Business Media. All Rights Reserved.
Lewis Business Media, Suite A, Arun House, Office Village, River Way, Uckfield, TN22 1SL

Privacy Policy | Cookie Policy | Terms & Conditions

  • OvertheCounter
  • Pest Magazine

Type above and press Enter to search. Press Esc to cancel.

Pet Business World
Managing Your Privacy

To provide the best digital experience, we use cookies to store and/or access device information. Consenting to our use of cookies allows us to process data such as reading behaviour. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Cookie Preferences
  • {title}
  • {title}
  • {title}